US Stock MarketDetailed Quotes
RSLS ReShape Lifesciences
- 5.9400
- +0.1900+3.30%
Close Nov 29 13:00 ET
- 5.5741
- -0.3659-6.16%
Post 17:02 ET
4.23MMarket Cap-592P/E (TTM)
5.9400High5.6207Low24.56KVolume5.7400Open5.7500Pre Close139.40KTurnover3.64%Turnover RatioLossP/E (Static)712.68KShares34.220052wk High2.85P/B4.01MFloat Cap4.600052wk Low--Dividend TTM674.87KShs Float4647888000.0000Historical High--Div YieldTTM5.55%Amplitude4.6000Historical Low5.6740Avg Price1Lot Size
About ReShape Lifesciences Company
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Company Profile
SymbolRSLS
Company NameReShape Lifesciences
Listing DateOct 6, 2016
Issue Price15.00
Founded2002
CEOMr. Paul F. Hickey
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address1001 Calle Amanecer
CitySan Clemente
ProvinceCalifornia
CountryUnited States of America
Zip Code92673
Phone1-949-429-6680
Company Executives
- Name
- Position
- Salary
- Paul F. Hickey
- Director, President and Chief Executive Officer
- 158.08K
- Thomas Stankovich
- Chief Financial Officer, Senior Vice President and Principal Accounting Officer
- 555.84K
- Dan W. Gladney
- Executive Chairman of the Board
- 95.26K
- Gary D. Blackford
- Lead Independent Director
- 77.00K
- Dr. Arda M. Minocherhomjee, M.B.A.,PhD
- Independent Director
- 52.50K
- Lori C. McDougal
- Independent Director
- 57.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data